- Country: Slovakia
- Summary: Anti-Infective Ii
- SKT Ref No: 128606391
- Deadline: 20 Nov 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: EUR 132753.50
- Notice Type: Tender
- Document Ref. No.: 693000-2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- The subject of the contract is the supply of medicines called Antiinfective II divided into two parts for a procurement period of 36 months. forms part of the tender documents B.2 Description of the subject of the contract.
injectable vial contains 100 mg of anidulafungin. group: J02AX06
medicine bottles in a package with a total number of 650 vials
vial contains 500 mg of vancomycin (in the form of chloride), which corresponds to 500,000 IU. 50 mg/ml vancomycin.
packs of 1 vial or in a different number of vials in a pack totaling 10,445 vials
items: Humane medicine
reconstitution with 20 ml water for injection contains a solution of 50 mg/ml vancomycin.
solution/powder ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINAnti-Infective Ii - Slovakia Tender
The NATIONAL INSTITUTE OF HEART AND VASCULAR DISEASES, A.S., a Government sector organization in Slovakia, has announced a new tender for Anti-Infective Ii. This tender is published on SlovakiaTenders under SKT Ref No: 128606391 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-11-20.
The estimated tender value is EUR 132753.50, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
